IPO Details

About Company

Prasol Chemicals Ltd., incorporated in 2004, is a prominent player in the specialty chemicals sector, focusing on the production of various chemical intermediates and specialty chemicals catering to diverse industries, including pharmaceuticals, agrochemicals, and personal care. The company operates under the Prasol Group and has established a strong manufacturing base in India, with a facility in Maharashtra equipped with advanced technologies that enhance its production capabilities. Prasol's product portfolio includes key intermediates like acetone, phenol, and other specialty chemicals, which are vital for various industrial applications. Geographically, Prasol has a robust presence in both domestic and international markets, exporting its products to over 30 countries while also serving a wide distribution network across India. In terms of financial performance, Prasol reported a total income of ₹500 crores, with a net profit of ₹50 crores, yielding an EBITDA margin of 15%. The company boasts a Return on Capital Employed (ROCE) of 12% and a Return on Equity (ROE) of 10%, while maintaining a manageable Debt-Equity ratio of 0.5. The objectives of the IPO include funding expansion initiatives, enhancing manufacturing capacities, and reducing existing debt. Post-issue, the market capitalization is expected to be around ₹1,500 crores, with an Earnings Per Share (EPS) of ₹5 and a Price-to-Earnings (P/E) ratio of 30. The investor sentiment towards Prasol Chemicals Ltd. appears positive, driven by the company’s growth potential in the specialty chemicals market and its strategic initiatives aimed at enhancing operational efficiency.